When you're a STAT+ subscriber, you get discounts on our STAT Reports and events, free access to premium data tools like our Obesity Drug Tracker, as well as daily coverage and analysis of the life sciences.
This exclusive report is the first comprehensive guide to how biotech and pharma companies are combating climate change, ranking them on their efforts to understand and reduce their greenhouse gas emissions. Based on data compiled from a variety of public sources, STAT conducted an exclusive analysis, using 20 different metrics to rate companies on transparency, credibility, scope, and implementation of climate policies.
There's just under one month left to get your ticket to join us for this year's STAT Summit. Over two packed days, you'll learn from the brightest minds, innovative leaders, and visionary thinkers from across the life sciences. Unlock the opportunity to network with other industry attendees and be a part of the conversation about what it takes to create a thriving health care system.
Subscribe to STAT+ to unlock a 20% discount on your ticket.
Free access:Track the significant obesity drugs that are on the market and in development
STAT's Obesity Drug Tracker captures the progress of dozens of new weight loss drugs in development or on the market, including obesity medications being cultivated by industry leaders Eli Lilly and Novo Nordisk.
STAT+ subscribers get free access to this tracker.
Sign up for STAT's free guide of this leading health tech conference. Get insights each day from reporters Mohana Ravindranath and Annalisa Merelli, who will be there in Vegas, sharing their perspectives from the conference floor.
.jpg?width=1200&upscale=true&name=23Summit_Email_v6%20(1).jpg)
No comments